Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The effect of caffeine dose on caffeine and paraxanthine changes in serum and saliva and CYP1A2 enzyme activity in athletes: a randomized placebo-controlled crossover trial

N. Główka, J. Malik, J. Anioła, EE. Zawieja, A. Chmurzynska, K. Durkalec-Michalski

. 2024 ; 21 (1) : 90. [pub] 20241111

Status not-indexed Language English Country England, Great Britain

Document type Journal Article

BACKGROUND: Although caffeine (CAF) supplementation has been shown to improve exercise performance, its dose-dependent effect on CAF metabolism has not been sufficiently investigated. The aim of this study was to evaluate the effects of 3, 6 and 9 mg of CAF/kgBM on changes of CAF and paraxanthine (PRX) in the serum and saliva at four time-points. METHODS: In a randomized, double-blind, placebo-controlled crossover design, acute pre-exercise supplementation in 26 moderately-trained athletes, participating in high-intensity functional training (HIFT), was examined. The study protocol involved CAF/PRX biochemical analyses of serum and saliva with respect to CYP1A2 polymorphism and CYP1A2 enzyme activity. RESULTS: Despite significant differences between the serum and saliva levels of CAF and PRX, there was no difference in the PRX/CAF ratio. The interaction effect of dose and time-points for PRX concentration was revealed. The main effects of dose were observed for CAF and the PRX/CAF ratio. The main effect of time-points was registered only for serum CAF. CONCLUSIONS: Dose- and time-dependent effect of CAF supplementation on CAF and PRX in the serum and saliva of athletes was confirmed, but there was no effect of the CAF dose on CYP1A2 enzyme activity, nor was there an interaction of CYP1A2 with enzyme inducibility. The CAF/PRX correlation indicated the possibility of interchangeable use of serum and/or saliva analyses in exercise studies. CLINICAL TRIAL REGISTRATION: This trial was registered prospectively at ClinicalTrials.gov (NCT03822663, registration date: 30/01/2019).

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25002165
003      
CZ-PrNML
005      
20250123102009.0
007      
ta
008      
250117s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12986-024-00863-3 $2 doi
035    __
$a (PubMed)39529054
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Główka, Natalia $u Department of Sports Dietetics, Poznan University of Physical Education, Poznań, 61- 871, Poland. glowka@awf.poznan.pl
245    14
$a The effect of caffeine dose on caffeine and paraxanthine changes in serum and saliva and CYP1A2 enzyme activity in athletes: a randomized placebo-controlled crossover trial / $c N. Główka, J. Malik, J. Anioła, EE. Zawieja, A. Chmurzynska, K. Durkalec-Michalski
520    9_
$a BACKGROUND: Although caffeine (CAF) supplementation has been shown to improve exercise performance, its dose-dependent effect on CAF metabolism has not been sufficiently investigated. The aim of this study was to evaluate the effects of 3, 6 and 9 mg of CAF/kgBM on changes of CAF and paraxanthine (PRX) in the serum and saliva at four time-points. METHODS: In a randomized, double-blind, placebo-controlled crossover design, acute pre-exercise supplementation in 26 moderately-trained athletes, participating in high-intensity functional training (HIFT), was examined. The study protocol involved CAF/PRX biochemical analyses of serum and saliva with respect to CYP1A2 polymorphism and CYP1A2 enzyme activity. RESULTS: Despite significant differences between the serum and saliva levels of CAF and PRX, there was no difference in the PRX/CAF ratio. The interaction effect of dose and time-points for PRX concentration was revealed. The main effects of dose were observed for CAF and the PRX/CAF ratio. The main effect of time-points was registered only for serum CAF. CONCLUSIONS: Dose- and time-dependent effect of CAF supplementation on CAF and PRX in the serum and saliva of athletes was confirmed, but there was no effect of the CAF dose on CYP1A2 enzyme activity, nor was there an interaction of CYP1A2 with enzyme inducibility. The CAF/PRX correlation indicated the possibility of interchangeable use of serum and/or saliva analyses in exercise studies. CLINICAL TRIAL REGISTRATION: This trial was registered prospectively at ClinicalTrials.gov (NCT03822663, registration date: 30/01/2019).
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Malik, Jakub $u Department of Pedagogy, Poznan University of Physical Education, Poznań, Poland
700    1_
$a Anioła, Jacek $u Department of Human Nutrition and Dietetics, Poznań University of Life Sciences, Poznań, Poland
700    1_
$a Zawieja, Emilia E $u Department of Human Nutrition and Dietetics, Poznań University of Life Sciences, Poznań, Poland
700    1_
$a Chmurzynska, Agata $u Department of Human Nutrition and Dietetics, Poznań University of Life Sciences, Poznań, Poland
700    1_
$a Durkalec-Michalski, Krzysztof $u Department of Sports Dietetics, Poznan University of Physical Education, Poznań, 61- 871, Poland. durkalec-michalski@awf.poznan.pl $u Sport Sciences-Biomedical Department, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic. durkalec-michalski@awf.poznan.pl
773    0_
$w MED00165928 $t Nutrition & metabolism $x 1743-7075 $g Roč. 21, č. 1 (2024), s. 90
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39529054 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250117 $b ABA008
991    __
$a 20250123102003 $b ABA008
999    __
$a ok $b bmc $g 2254492 $s 1238168
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 21 $c 1 $d 90 $e 20241111 $i 1743-7075 $m Nutrition & metabolism $n Nutr Metab (Lond) $x MED00165928
LZP    __
$a Pubmed-20250117

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...